KALA PHARMACEUTICALS INC's ticker is KALA and the CUSIP is 483119103. A total of 73 filers reported holding KALA PHARMACEUTICALS INC in Q3 2018. The put-call ratio across all filers is 0.25 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $7,881 | -78.0% | 25,874 | 0.0% | 0.00% | -66.7% |
| Q1 2022 | $35,853 | +128.8% | 25,874 | 0.0% | 0.00% | +50.0% |
| Q4 2021 | $15,670 | -53.8% | 25,874 | 0.0% | 0.00% | -60.0% |
| Q3 2021 | $33,929 | -50.6% | 25,874 | 0.0% | 0.01% | -50.0% |
| Q2 2021 | $68,635 | -21.4% | 25,874 | 0.0% | 0.01% | -28.6% |
| Q1 2021 | $87,282 | -0.6% | 25,874 | 0.0% | 0.01% | 0.0% |
| Q4 2020 | $87,801 | -9.6% | 25,874 | 0.0% | 0.01% | -41.7% |
| Q3 2020 | $97,125 | +56.8% | 25,874 | +119.8% | 0.02% | +14.3% |
| Q2 2020 | $61,934 | +19.6% | 11,774 | 0.0% | 0.02% | -4.5% |
| Q1 2020 | $51,799 | +138.2% | 11,774 | 0.0% | 0.02% | +175.0% |
| Q4 2019 | $21,745 | -3.0% | 11,774 | 0.0% | 0.01% | -20.0% |
| Q3 2019 | $22,422 | -40.4% | 11,774 | 0.0% | 0.01% | -47.4% |
| Q2 2019 | $37,597 | -22.9% | 11,774 | 0.0% | 0.02% | -26.9% |
| Q1 2019 | $48,734 | +69.1% | 11,774 | 0.0% | 0.03% | +73.3% |
| Q4 2018 | $28,816 | -50.5% | 11,774 | 0.0% | 0.02% | -53.1% |
| Q3 2018 | $58,163 | -28.1% | 11,774 | 0.0% | 0.03% | -45.8% |
| Q2 2018 | $80,910 | +56.1% | 11,774 | +80.0% | 0.06% | +47.5% |
| Q1 2018 | $51,832 | – | 6,542 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Parallel Advisors, LLC | 1 | $9 | 0.00% |